Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-20-002557

Options or other derivatives

  • Chief Clinical Affairs Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Graham Camilla · Chief Clinical Affairs Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-04 Grant or award : show line 1 in the form Stock Option (right to buy) +400,000 $3.34 $1,336,000 400,000 D
Loading xslF345X03/form412566002_10072020.xml…